Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05699070
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2023-04-04
First Post:
2023-01-10
Brief Title:
Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects
Sponsor:
Daewoong Pharmaceutical Co LTD
Organization:
Daewoong Pharmaceutical Co LTD
Study Overview
Official Title:
An Open-label Phase 1 Study to Evaluate PharmacokineticPharmacodynamic Drug-drug Interactions and SafetyTolerability of DWC202211 and DWC202212 Compared to Coadministration in Healthy
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DWJ1610
Brief Summary:
An open-label phase 1 study to evaluate pharmacokineticpharmacodynamic drug-drug interactions and safetytolerability of DWC202211 and DWC202212 compared to coadministration in healthy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None